Ventyx Biosciences, Inc. Income Statement

Income Statement Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue -0.36M-0.10M
Gross Profit -0.36M-0.10M
Operating items
Research & Development 6.37M58.48M
Selling, General & Administrative 0.68M8.67M
Operating Expenses 7.05M67.15M
Operating Income -7.05M-67.15M-113.14M
EBIT -7.05M-67.15M-113.14M
Non-operating items
Interest & Investment Income 0.08M
Other Non Operating Income -0.00M-0.05M
Non Operating Income -21.12M-16.60M4.71M
Net income details
EBT -7.41M-59.15M-56.35M
Profit After Tax -28.17M-83.75M-108.43M
Income from Continuing Operations -7.41M-59.15M-56.35M
Consolidated Net Income -7.41M-59.15M-56.35M
Income towards Parent Company -7.41M-59.15M-56.35M
Preferred Dividend Payments 1.55M
Net Income towards Common Stockholders -28.17M-85.30M-56.35M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M
Shares Outstanding (Weighted Average) 50.30M56.64M59.05M70.71M
EBITDA -7.05M-67.15M-109.49M